LifeMD Inc Cash Flow Conversion Efficiency
LifeMD Inc cash flow conversion efficiency. Based on the latest financial reports, LifeMD Inc (LFMD) has a cash flow conversion efficiency ratio of -0.142x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.28 Million) by net assets ($23.16 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of LifeMD Inc (2011–2025)
Cash flow conversion efficiency of LifeMD Inc from 2011 to 2025. This chart illustrates how LifeMD Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View LFMD live share price for real-time trading data and today's change.
LifeMD Inc Cash Flow Conversion Ratio Explained
LifeMD Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
LifeMD Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of LifeMD Inc ranked by their cash flow conversion efficiency. Also see market value of LifeMD Inc for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Creades AB Series A
LSE:0QI9
|
-0.001x |
|
YFC-BonEagle Electric Co Ltd
TWO:6220
|
0.174x |
|
Luxchem Corporation Bhd
KLSE:5143
|
-0.001x |
|
ARRAIL GROUP LTD.
F:I1D
|
N/A |
|
Chinyang Hold
KO:100250
|
-0.015x |
|
I Controls Inc
KO:039570
|
-0.071x |
|
GoldMoney Inc
TO:XAU
|
0.050x |
|
Schroders PLC
LSE:SDR
|
0.043x |
Annual Cash Flow Conversion Efficiency for LifeMD Inc (2011–2025)
The table below shows the annual cash flow conversion efficiency of LifeMD Inc from 2011 to 2025. Review LifeMD Inc (LFMD) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $23.16 Million | $8.28 Million | 0.358x | +108.26% |
| 2024-12-31 | $-4.05 Million | $17.51 Million | -4.329x | -373.20% |
| 2023-12-31 | $5.57 Million | $8.82 Million | 1.585x | -49.53% |
| 2022-12-31 | $-7.31 Million | $-22.94 Million | 3.139x | +344.99% |
| 2021-12-31 | $25.82 Million | $-33.09 Million | -1.281x | -108.68% |
| 2020-12-31 | $-821.76K | $-12.13 Million | 14.763x | +6731.00% |
| 2019-12-31 | $-1.13 Million | $251.41K | -0.223x | +79.85% |
| 2018-12-31 | $819.74K | $-905.52K | -1.105x | +15.81% |
| 2017-12-31 | $622.84K | $-817.22K | -1.312x | -216.35% |
| 2016-12-31 | $-361.73K | $-407.91K | 1.128x | +169.16% |
| 2015-12-31 | $180.99K | $-295.12K | -1.631x | -580.24% |
| 2014-12-31 | $-139.50K | $33.44K | -0.240x | +81.91% |
| 2013-12-31 | $195.49K | $-259.07K | -1.325x | +22.12% |
| 2012-12-31 | $135.00K | $-229.73K | -1.702x | -2822.77% |
| 2011-12-31 | $-282.98K | $-17.69K | 0.062x | -- |
About LifeMD Inc
LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature e… Read more